Cargando…
Development of Test Programs for the Biorelevant Characterization of Esophageal-Applied Dosage Forms
In the local treatment of the esophageal mucosa, the retention time of the different dosage forms, such as tablets, films or liquids, is of high relevance for the effective treatment of diseases. Unfortunately, there are only few in vitro models describing the esophageal route of administration. To...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459172/ https://www.ncbi.nlm.nih.gov/pubmed/37631487 http://dx.doi.org/10.3390/polym15163430 |
_version_ | 1785097346018705408 |
---|---|
author | Brokmann, Friederike Feindt, Franziska Weitschies, Werner Rosenbaum, Christoph |
author_facet | Brokmann, Friederike Feindt, Franziska Weitschies, Werner Rosenbaum, Christoph |
author_sort | Brokmann, Friederike |
collection | PubMed |
description | In the local treatment of the esophageal mucosa, the retention time of the different dosage forms, such as tablets, films or liquids, is of high relevance for the effective treatment of diseases. Unfortunately, there are only few in vitro models describing the esophageal route of administration. To predict the behaviour of an esophageal-applied dosage form, it is necessary to simulate the site of application in a biorelevant way. The aim of this work was to develop two test setups for an esophageal peristalsis model which was described in a previous study. Different parameters such as flow rate, peristalsis, angle of inclination or mucous membrane were varied or introduced into the model. A stimulated and unstimulated modus were developed and tested with two different dosage forms. The time until the dosage form was cleared from the in vitro model was shorter with the stimulated than with the unstimulated modus. Also, esophageal-applied films had a prolonged transit time compared to a viscous syrup. The modification of the simulated esophageal surface made it possible to estimate the retention time of the dosage forms. It could be demonstrated that the residence time of a dosage form depends on different parameters affecting each other. |
format | Online Article Text |
id | pubmed-10459172 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104591722023-08-27 Development of Test Programs for the Biorelevant Characterization of Esophageal-Applied Dosage Forms Brokmann, Friederike Feindt, Franziska Weitschies, Werner Rosenbaum, Christoph Polymers (Basel) Article In the local treatment of the esophageal mucosa, the retention time of the different dosage forms, such as tablets, films or liquids, is of high relevance for the effective treatment of diseases. Unfortunately, there are only few in vitro models describing the esophageal route of administration. To predict the behaviour of an esophageal-applied dosage form, it is necessary to simulate the site of application in a biorelevant way. The aim of this work was to develop two test setups for an esophageal peristalsis model which was described in a previous study. Different parameters such as flow rate, peristalsis, angle of inclination or mucous membrane were varied or introduced into the model. A stimulated and unstimulated modus were developed and tested with two different dosage forms. The time until the dosage form was cleared from the in vitro model was shorter with the stimulated than with the unstimulated modus. Also, esophageal-applied films had a prolonged transit time compared to a viscous syrup. The modification of the simulated esophageal surface made it possible to estimate the retention time of the dosage forms. It could be demonstrated that the residence time of a dosage form depends on different parameters affecting each other. MDPI 2023-08-17 /pmc/articles/PMC10459172/ /pubmed/37631487 http://dx.doi.org/10.3390/polym15163430 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Brokmann, Friederike Feindt, Franziska Weitschies, Werner Rosenbaum, Christoph Development of Test Programs for the Biorelevant Characterization of Esophageal-Applied Dosage Forms |
title | Development of Test Programs for the Biorelevant Characterization of Esophageal-Applied Dosage Forms |
title_full | Development of Test Programs for the Biorelevant Characterization of Esophageal-Applied Dosage Forms |
title_fullStr | Development of Test Programs for the Biorelevant Characterization of Esophageal-Applied Dosage Forms |
title_full_unstemmed | Development of Test Programs for the Biorelevant Characterization of Esophageal-Applied Dosage Forms |
title_short | Development of Test Programs for the Biorelevant Characterization of Esophageal-Applied Dosage Forms |
title_sort | development of test programs for the biorelevant characterization of esophageal-applied dosage forms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459172/ https://www.ncbi.nlm.nih.gov/pubmed/37631487 http://dx.doi.org/10.3390/polym15163430 |
work_keys_str_mv | AT brokmannfriederike developmentoftestprogramsforthebiorelevantcharacterizationofesophagealapplieddosageforms AT feindtfranziska developmentoftestprogramsforthebiorelevantcharacterizationofesophagealapplieddosageforms AT weitschieswerner developmentoftestprogramsforthebiorelevantcharacterizationofesophagealapplieddosageforms AT rosenbaumchristoph developmentoftestprogramsforthebiorelevantcharacterizationofesophagealapplieddosageforms |